Medical plastic classification testing is a critical quality assurance process that verifies the biocompatibility, chemical safety, and mechanical performance of polymeric materials used in medical devices and healthcare products. This technical guide explains the major classification systems, including USP Class VI and the ISO 10993 series, along with the testing items, methodologies, and application requirements that manufacturers must satisfy to bring compliant medical plastics to market.
Technical Overview
Medical plastic classification testing is the systematic evaluation of polymeric materials intended for direct or indirect patient contact in medical devices, drug delivery systems, and healthcare products. The objective is to assign each material a verified safety grade by assessing its biological response, chemical stability, extractables profile, and physical performance under simulated clinical use conditions. Because medical plastics contact tissue, blood, and pharmaceutical formulations, regulatory bodies require documented evidence of material safety before market approval.
The modern testing framework follows the risk-based approach defined in ISO 10993-1, which assigns evaluation endpoints according to the nature of body contact (surface-contacting, externally communicating, or implantable) and the duration of contact (limited up to 24 hours, prolonged from 24 hours to 30 days, or permanent beyond 30 days). In China, the equivalent national standard series GB/T 16886 adopts the same technical structure, while GB/T 14233 governs test methods for infusion and transfusion equipment.
A parallel grading system exists in the United States Pharmacopeia (USP), where plastics are classified into six biological reactivity classes under USP <88>. USP Class VI represents the most demanding tier, requiring systemic injection, intracutaneous, and muscle implantation tests using multiple polar and non-polar extraction media prepared under stringent extraction conditions. Testing is typically performed by accredited third-party laboratories operating under ISO/IEC 17025 quality management and supporting ISO 13485 and ISO 14971 risk management documentation.
Testing Samples
Raw Polymer Resins and Compounds
Pellets, powders, and masterbatches are tested at the material level to establish baseline composition, monomer residuals, additive packages, plasticizer content, and melt flow behavior. Resin-level characterization supports material master file development and supplier qualification before commercial production begins.
Finished and Semi-Finished Device Components
Syringe barrels, infusion set components, catheter shafts, luer connectors, dialyzer housings, and respiratory circuits are evaluated in their final processed and sterilized state. This ensures that molding, extrusion, assembly, and sterilization histories are reflected in the biological and chemical results.
Films, Sheets, and Tubing
Extruded and calendared materials used for blood bags, solution containers, wound dressings, and transfer tubing are tested using surface-area-based extraction protocols, since patient exposure for these geometries is governed by contact area rather than mass.
Material Extracts and Leachables
Liquid extracts generated under standardized conditions serve as the test article for most biological endpoints and for analytical characterization of extractables and leachables migrating from the polymer matrix.
Testing Items
The specific test panel depends on the target classification grade, device contact category, and contact duration. Typical testing items include:
- In vitro cytotoxicity evaluation
- Skin sensitization and irritation testing
- Intracutaneous reactivity assessment
- Acute systemic toxicity testing
- Genotoxicity, sub-chronic toxicity, and implantation studies for prolonged and permanent applications
- Hemocompatibility testing, including hemolysis, complement activation, and coagulation interaction
- Chemical characterization of extractables and leachables, monomers, oligomers, additives, and degradation products
- Elemental impurity screening for heavy metals and catalyst residues
- Plasticizer quantification, including phthalate content in flexible PVC
- Tensile strength, elongation, flexural modulus, impact resistance, and hardness verification
- Thermal properties, including glass transition, melting point, crystallinity, and oxidative induction time
- Ethylene oxide and ethylene chlorohydrin residual analysis after sterilization
Biological Safety Evaluation
Biological endpoints are selected from the ISO 10993-1 evaluation matrix. Cytotoxicity, sensitization, and irritation form the core panel for most surface-contacting and short-term devices, while blood-contacting devices add hemocompatibility and material-mediated pyrogenicity studies.
Chemical Characterization and Extractables–Leachables Studies
ISO 10993-18 requires a documented chemical characterization of the material, identifying and quantifying extractable substances. Results feed into a toxicological risk assessment conducted under ISO 10993-17 to demonstrate that patient exposure remains below safety thresholds.
Physical and Mechanical Properties
Mechanical integrity is verified to confirm that processed components retain the strength, flexibility, and dimensional stability required for clinical handling, fluid pressure, and long-term storage.
Sterilization Compatibility and Residuals
Materials are challenged after exposure to ethylene oxide, gamma, electron beam, or steam sterilization to confirm that sterilization does not degrade biological or mechanical performance, and that residuals comply with ISO 10993-7 limits.
Testing Methods
Sample Preparation and Extraction
Sample preparation follows ISO 10993-12, which defines standardized surface-area-to-volume or mass-to-volume extraction ratios, typically 3 cm²/mL or 6 cm²/mL for flat specimens and 0.1–0.2 g/mL for irregular geometries. Polar media such as saline and non-polar media such as cottonseed or sesame oil, polyethylene glycol 400, and ethanol-water mixtures are used to capture both hydrophilic and lipophilic extractables. Extraction conditions range from physiological simulation at 37 °C for 72 hours to exaggerated conditions at elevated temperatures.
In Vitro Cytotoxicity Testing
Cytotoxicity is assessed per ISO 10993-5 using the extract elution method with mammalian cell lines, most commonly the MTT reduction assay, alongside direct contact and agar diffusion options. Cell viability of at least 70 percent relative to controls is the standard acceptance criterion for a non-cytotoxic classification.
Sensitization, Irritation, and Intracutaneous Reactivity
Sensitization potential is evaluated under ISO 10993-10 using the guinea pig maximization test or the murine local lymph node assay, while irritation and intracutaneous reactivity follow ISO 10993-10 and ISO 10993-23, combining in vivo rabbit scoring protocols with validated in vitro reconstructed human tissue models where accepted.
USP Class VI Biological Panel
The USP <88> Class VI program comprises a systemic injection test in mice, an intracutaneous test in rabbits, and a short-term muscle implantation test in rabbits. Four extraction solvents are employed, with the highest class requiring extraction under the most aggressive conditions specified in the general chapter, in addition to an in vitro screening under USP <87>.
Analytical Chemistry Methods
Chemical characterization combines gas chromatography–mass spectrometry, liquid chromatography–tandem mass spectrometry, headspace gas chromatography, and inductively coupled plasma mass spectrometry to identify organic extractables, volatile species, and elemental impurities. Fourier-transform infrared spectroscopy confirms polymer identity and detects surface contamination or post-sterilization chemical change.
Mechanical and Thermal Characterization
Tensile and elongation properties are measured under ISO 527 or ASTM D638, flexural behavior under ISO 178 or ASTM D790, and impact resistance under ISO 179 or ASTM D256. Hardness is determined by Shore durometry per ISO 868 or ASTM D2240. Differential scanning calorimetry, thermogravimetric analysis, and melt flow rate testing per ISO 1133 complete the material profile.
Sterile Barrier and Stability Testing
Ethylene oxide residuals are quantified by headspace gas chromatography per ISO 10993-7. Accelerated aging under ASTM F1980 and real-time aging programs demonstrate that classified performance is maintained through the labeled shelf life of the finished device.
Applications
Infusion, Transfusion, and Drug Delivery
Flexible PVC and PVC-free alternatives such as thermoplastic polyurethane and polyolefin blends are graded for IV bags, blood bags, infusion sets, and syringes, where prolonged fluid contact demands rigorous hemocompatibility and leachables control.
Surgical and Implantable Devices
High-performance polymers including PEEK, UHMWPE compliant with ISO 5834, and medical-grade silicones undergo permanent-contact evaluation for spinal cages, orthopedic bearing surfaces, pacemaker leads, and long-term catheters.
Diagnostics and Laboratory Consumables
Polystyrene, polypropylene, polycarbonate, and cyclic olefin polymers used for petri dishes, pipette tips, cuvettes, and microfluidic cartridges are classified to ensure assay compatibility and to prevent leachable interference with diagnostic results.
Sterile Barrier Packaging
Polyester trays, breathable polyethylene films, and multilaminated pouches are evaluated against the sterile barrier requirements of ISO 11607, combining microbial barrier performance with material safety classification for packaging that contacts the device.
FAQ
What is the difference between USP Class VI and ISO 10993?
USP Class VI is a fixed six-tier plastics grading system based on a defined set of in vivo tests, while the ISO 10993 series applies a risk-based framework in which test selection depends on device contact type and duration. Many manufacturers pursue both, using USP Class VI as a material screening benchmark and ISO 10993 for device-specific biological evaluation.
Which materials typically require the highest classification grade?
Materials intended for implantable devices, blood contact beyond 24 hours, or permanent body contact generally require the most complete evaluation panels, including implantation, sub-chronic toxicity, and comprehensive chemical characterization.
How long does classification testing take?
Core cytotoxicity, irritation, and sensitization studies typically require four to eight weeks. Full Class VI panels or permanent-contact ISO 10993 programs, including chemical characterization and toxicological assessment, may extend from three to six months.
What sample quantities are needed for testing?
Requirements vary by test method, but a typical program requires several hundred grams of resin or a comparable quantity of finished components, sufficient to prepare extracts for the complete biological and analytical panel at the specified extraction ratios.
When must a classified material be retested?
Retesting is triggered by changes in resin supplier, formulation, processing conditions, or sterilization method, as well as by significant regulatory updates to the governing standards. Otherwise, validated classification data can support a device throughout its lifecycle under a maintained ISO 13485 quality system.
Can one classification cover multiple devices?
A material-level classification can be leveraged across multiple products, provided the contact category, contact duration, and processing conditions fall within the evaluated envelope. Device-specific verification is still required where geometry or use conditions differ materially.